Advertisement #1
Home Tags AML

Tag: AML

General Views during at the American Society of Hematology 61th Annual Meeting at the Orange County Convention Center. Photo Courtesy © 2019 ASH/Danny Morton.

ASH 2020: Preclinical Models Identify CD74 as Potential Target for the...

Peter Hofland, Ph.D -
Speakers and attendees during Poster Session 1 at the American Society of Hematology 61th Annual Meeting at the Orange County Convention Center, Friday December 6, 2019. Photo Courtesy American Society of Hematology © 2019 ASH/Nick Agro

ASCO 2020: How Disparities and Inequities Affect Health

Danielle Garcia -
AbbVie booth at the 2019 annual meeting of the American Society of Clinical Oncology (ASCO) held June 1 - 4, 2019 in Chicago, Ill.

U.S. FDA Approves Venetoclax for the Treatment of Acute Myeloid Leukemia

Editorial Team -

A Compound Being Developed to Treat an Eye Disease may also...

Peter Hofland, Ph.D -

Daiichi Sankyo Initiates Phase I Study to Evaluate the Combination Quizartinib...

Peter Hofland, Ph.D -

Gilteritinib Available for Prescription in the United States for Adults with...

Peter Hofland, Ph.D -

Glasdegib Approved in Newly-Diagnosed AML Patients for Whom Intensive Chemotherapy is...

Peter Hofland, Ph.D -

FDA Grants Accelerated Approval for Venetoclax in Newly-Diagnosed Acute Myeloid Leukemia...

Peter Hofland, Ph.D -

Anti-Leukemic Activity and Safety Data for Gilteritinib in Relapsed

Peter Hofland, Ph.D -

First Patient with Untreated High-risk Acute Myeloid Leukemia Enrolled in Phase...

Editorial Team -

LATEST NEWS

Advertisment #12
© 2001 - 2020 Sunvalley Communication, LLC. All Rights Reserved.